Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100189265 | 10018926 | 5 | F | 2011 | 20160712 | 20140318 | 20160713 | EXP | US-GLAXOSMITHKLINE-A1064125A | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160713 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100189265 | 10018926 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 250/50, 1 DF, BID | Y | 4ZP2869 | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
100189265 | 10018926 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 250/50 UG, 1 DF, QD | Y | 4ZP5605 | 21077 | 1 | DF | INHALATION POWDER | QD | ||||
100189265 | 10018926 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 500/50 UG, U | Y | 21077 | INHALATION POWDER | ||||||||
100189265 | 10018926 | 4 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 250/50 UG, UNK, U | Y | 21077 | INHALATION POWDER | ||||||||
100189265 | 10018926 | 5 | SS | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | 90 MCG, UNKNOWN DOSING | U | 0 | 90 | UG | |||||||
100189265 | 10018926 | 6 | SS | VENTOLIN | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
100189265 | 10018926 | 7 | SS | VENTOLIN | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
100189265 | 10018926 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
100189265 | 10018926 | 9 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
100189265 | 10018926 | 10 | C | METHOCARBAMOL. | METHOCARBAMOL | 1 | 0 | ||||||||||||
100189265 | 10018926 | 11 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
100189265 | 10018926 | 12 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
100189265 | 10018926 | 13 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
100189265 | 10018926 | 14 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
100189265 | 10018926 | 15 | C | Cyclobenzaprine | CYCLOBENZAPRINE | 1 | U | 0 | |||||||||||
100189265 | 10018926 | 16 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
100189265 | 10018926 | 17 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
100189265 | 10018926 | 18 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | U | 0 | |||||||||||
100189265 | 10018926 | 19 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
100189265 | 10018926 | 20 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
100189265 | 10018926 | 21 | C | NAPROXEN. | NAPROXEN | 1 | 0 | ||||||||||||
100189265 | 10018926 | 22 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100189265 | 10018926 | 1 | Chronic obstructive pulmonary disease |
100189265 | 10018926 | 2 | Asthma |
100189265 | 10018926 | 5 | Chronic obstructive pulmonary disease |
100189265 | 10018926 | 6 | Asthma |
100189265 | 10018926 | 7 | Emphysema |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100189265 | 10018926 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100189265 | 10018926 | Arthralgia | |
100189265 | 10018926 | Blood calcium decreased | |
100189265 | 10018926 | Bone disorder | |
100189265 | 10018926 | Candida infection | |
100189265 | 10018926 | Cough | |
100189265 | 10018926 | Device use error | |
100189265 | 10018926 | Dizziness | |
100189265 | 10018926 | Drug administration error | |
100189265 | 10018926 | Drug ineffective | |
100189265 | 10018926 | Dry mouth | |
100189265 | 10018926 | Dyspnoea | |
100189265 | 10018926 | Dyspnoea exertional | |
100189265 | 10018926 | Emphysema | |
100189265 | 10018926 | Eye pain | |
100189265 | 10018926 | Malaise | |
100189265 | 10018926 | Multiple sclerosis | |
100189265 | 10018926 | Muscle spasms | |
100189265 | 10018926 | Off label use | |
100189265 | 10018926 | Oral candidiasis | |
100189265 | 10018926 | Oropharyngeal candidiasis | |
100189265 | 10018926 | Oropharyngeal pain | |
100189265 | 10018926 | Osteoporosis | |
100189265 | 10018926 | Overdose | |
100189265 | 10018926 | Pain in jaw | |
100189265 | 10018926 | Therapy cessation | |
100189265 | 10018926 | Throat irritation | |
100189265 | 10018926 | Tooth disorder | |
100189265 | 10018926 | Tooth extraction | |
100189265 | 10018926 | Visual acuity reduced | |
100189265 | 10018926 | Wheezing | |
100189265 | 10018926 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100189265 | 10018926 | 1 | 201106 | 0 | ||
100189265 | 10018926 | 2 | 2011 | 0 | ||
100189265 | 10018926 | 5 | 1995 | 0 |